Edesa Biotech Inc (EDSA)
4.10
-0.05
(-1.20%)
USD |
NASDAQ |
Jun 26, 11:27
Edesa Biotech Revenue (Annual)
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| September 30, 2020 | 0.3288M |
| September 30, 2019 | 0.4109M |
| September 30, 2018 | 0.2118M |
| September 30, 2017 | 0.2283M |
| September 30, 2016 | 1.272M |
| September 30, 2015 | 0.7587M |
| Date | Value |
|---|---|
| September 30, 2014 | 0.0528M |
| August 31, 2014 | 0.3721M |
| August 31, 2013 | 0.5455M |
| August 31, 2012 | 0.2861M |
| August 31, 2011 | 0.6972M |
| August 31, 2010 | 0.8548M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
0.3288M
Minimum
2020
0.4109M
Maximum
2019
0.3698M
Average
0.3698M
Median
Revenue (Annual) Benchmarks
| Acasti Pharma Inc | -- |
| Aurinia Pharmaceuticals Inc | 175.51M |
| Lexaria Bioscience Corp | 0.2262M |
| Xenon Pharmaceuticals Inc | -- |
| ESSA Pharma Inc | -- |